Loading comparison data...
Medical Disclaimer: This site provides informational comparisons only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before making medication decisions.
Compare Tofacitinib (Xeljanz) and Tralokinumab (Adbry) — clinical data, side effects, and patient experiences.
Xeljanz · JAK Inhibitor
How it works
Inhibits Janus kinases JAK1 and JAK3, modulating the signalling of interleukins and interferons involved in immune and inflammatory pathways.
Approved for
Adbry · Biologic (IL-13 Inhibitor)
How it works
Monoclonal antibody that specifically binds to IL-13 cytokine, inhibiting its interaction with IL-13 receptors. Reduces type 2 inflammation in atopic dermatitis.
Approved for
Estimated frequency (%) based on clinical trial data
Based on 14 Reddit discussions
Tofacitinib
0%
positive
0 threads
Tralokinumab
21%
positive
14 threads
% of discussions mentioning each side effect
No community discussions found for Tofacitinib yet.
14 Reddit threads analysed for Tralokinumab
Overall Sentiment
Mixed
Comparison Threads
0
Avg Post Score
10 upvotes
Most discussed side effects in community
Apologies in advance for the emotional post. I have suffered with eczema my whole life but in the last 12 months it has been horrendous. I am a 28F and have failed protopic, steroids, light therapy, Rinvoq 30mg and now Adbry A.K.A Tralokinumab. 6 years ago I was prescribed Azathioprine which was a m
I’m so sorry for a long post. I’m really fed up and just probably looking for some solidarity or general positive chat about this. I’m feeling really hopeless. My skin is horrific and I’m just so unwell and hideous with it. I spent a lot of 2023 in psychiatric hospital and have told myself I’ll nev
So I've realized over the last few weeks that I am constantly fatigued. No amount of coffee, sleep, or resting seems to give me a boost. I struggle to get out of bed in the morning and yawn my way through the day, sometimes nearly falling asleep at my desk at work or at a traffic light. All day I ju
Hi r/eczema, I just wanted to share my experience with this trial drug. I had been on steroid creams to try and control my eczema for the longest and it would clear up my flares ups but I was getting quite tired of the cream. My dermatologist suggested this trial and I went for it. Weeks 1-6 were ho
Hello all! I went to the allergist today and am all signed up for a trial for "tralokinumab". It is an injectable in the same drug class as Dupixent which everyone seem to be having great success with. Has anyone tried "tralokinumab" or is anyone else starting the trial now or soon?
So someone contacted me for a bit of an update on Dupixent/Dupilumab in Australia after I made fairly detailed post a few months ago. NB: I don't work for Sanofi, nor do i work in the medical or pharmaceutical industry so i'm certainly not an authoritative source; I'm just a heavily invested party
Got accepted several weeks ago to the Phase 2b trial. I have a 3 in 4 chance of getting the medication. Got my first injections yesterday. Has anyone else done this study?
Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.
Tofacitinib is a JAK Inhibitor, while Tralokinumab belongs to the Biologic (IL-13 Inhibitor) class. This means they work through different pharmacological mechanisms, which may influence both efficacy and side effect profiles. Tofacitinib is administered via Oral, whereas Tralokinumab uses Subcutaneous. Route of administration can affect onset of action and patient adherence.
Tofacitinib carries 2 FDA warnings. Tralokinumab carries 3 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..
This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.